{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:31:41Z","timestamp":1789587101836,"version":"build-2803163510"},"reference-count":69,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Platelets express ABH antigens, which can adversely effect platelet transfusion recovery and survival in ABH-incompatible recipients. To date, there has been no large, comprehensive study comparing specific donor factors with ABH expression on platelet membranes and glycoconjugates. We studied ABH expression in 166 group A apheresis platelet donors by flow cytometry, Western blotting, and thin layer chromatography relative to donor age, sex, A1\/A2 subgroup, and Lewis phenotype. Overall, A antigen on platelet membranes, glycoproteins, and glycosphingolipids was linked to an A1 red blood cell (RBC) phenotype. Among A1 donors, platelet ABH varied significantly between donors (0%-87%). Intradonor variability, however, was minimal, suggesting that platelet ABH expression is a stable, donor-specific characteristic, with 5% of A1 donors typing as either ABH high- or low-expressers. Group A2 donors, in contrast, possessed a Bombay-like phenotype, lacking both A and H antigens. Unlike RBCs, ABH expression on platelets may be determined primarily by H-glycosyltransferase (FUT1) activity. Identification of A2 and A1 low expressers may increase the availability and selection of crossmatched and HLA-matched platelets. Platelets from group A2 may also be a superior product for patients undergoing A\/O major mismatch allogeneic progenitor cell transplantation. (Blood. 2005;105:3356-3364)<\/jats:p>","DOI":"10.1182\/blood-2004-08-3080","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T02:54:04Z","timestamp":1103684044000},"page":"3356-3364","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":83,"title":["Determinants of ABH expression on human blood platelets"],"prefix":"10.1182","volume":"105","author":[{"given":"Laura L. W.","family":"Cooling","sequence":"first","affiliation":[{"name":"From the Department of Pathology, University of Michigan, Ann Arbor, MI; and the Department of Pathology, University of Iowa, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Kelly","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of Michigan, Ann Arbor, MI; and the Department of Pathology, University of Iowa, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Barton","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of Michigan, Ann Arbor, MI; and the Department of Pathology, University of Iowa, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Hwang","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of Michigan, Ann Arbor, MI; and the Department of Pathology, University of Iowa, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore A. W.","family":"Koerner","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of Michigan, Ann Arbor, MI; and the Department of Pathology, University of Iowa, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Olson","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of Michigan, Ann Arbor, MI; and the Department of Pathology, University of Iowa, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218481207200_REF1","unstructured":"Holgersson J, Breimer ME, Samuelsson BE. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids. APMIS. 1992;100: 18-27."},{"key":"2020021218481207200_REF2","doi-asserted-by":"crossref","unstructured":"Holgersson J, Breimer ME, Jacobsson, Svensson L, Ulfvin A, Samuelsson BE. Glycolipid- and glycoprotein-based blood group A antigen expression in human thrombocytes: A1\/A2 difference. Glycoconjugate J. 1990;7: 601-608.","DOI":"10.1007\/BF01189080"},{"key":"2020021218481207200_REF3","doi-asserted-by":"crossref","unstructured":"Cooling LLW, Zhang D, Koerner TAW. Human platelets express gangliosides with LKE activity and ABH blood group activity. Transfusion. 2001;41: 504-516.","DOI":"10.1046\/j.1537-2995.2001.41040504.x"},{"key":"2020021218481207200_REF4","doi-asserted-by":"crossref","unstructured":"Santoso S, Kiefel V, Mueller-Eckhardt C. Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib. Thromb Haemostasis. 1991;65: 196-201.","DOI":"10.1055\/s-0038-1647483"},{"key":"2020021218481207200_REF5","doi-asserted-by":"crossref","unstructured":"Stockelberg D, Hou M, Rydberg L, Kutti J, Wadenvik H. Evidence for an expression of blood group A antigen on platelet glycoproteins IV and V. Transfusion Med. 1996;6: 243-248.","DOI":"10.1111\/j.1365-3148.1996.tb00075.x"},{"key":"2020021218481207200_","doi-asserted-by":"crossref","unstructured":"Kelton JG, Smith JW, Horsewood P, et al. ABH antigens on human platelets: expression on the glycosyl phosphatidylinositol-anchored protein CD109. J Lab Clin Med. 1998;132: 142-148.","DOI":"10.1016\/S0022-2143(98)90009-9"},{"key":"2020021218481207200_REF7","doi-asserted-by":"crossref","unstructured":"Mollicone R, Caillard T, Le Pendu J, et al. Expression of ABH and X (LeX) antigens on platelets and lymphocytes. Blood. 1988;71: 1113-1119.","DOI":"10.1182\/blood.V71.4.1113.1113"},{"key":"2020021218481207200_REF8","unstructured":"Cooling L. ABO and human blood platelets. Advance Admin Lab. 2004;13: 72-78."},{"key":"2020021218481207200_REF9","doi-asserted-by":"crossref","unstructured":"Aster RH. Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood. 1965;26: 732-743.","DOI":"10.1182\/blood.V26.6.732.732"},{"key":"2020021218481207200_REF10","doi-asserted-by":"crossref","unstructured":"Jimenez TM, Patel SB, Pineda AA, Tefferi A, Owen WG. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility. Transfusion. 2003;43: 328-334.","DOI":"10.1046\/j.1537-2995.2003.00326.x"},{"key":"2020021218481207200_REF11","doi-asserted-by":"crossref","unstructured":"Heal JM, Blumberg N, Masel D. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusion to refractory patients. Blood. 1987;70: 23-30.","DOI":"10.1182\/blood.V70.1.23.23"},{"key":"2020021218481207200_REF12","doi-asserted-by":"crossref","unstructured":"Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Heamatol. 1990;75: 408-413.","DOI":"10.1111\/j.1365-2141.1990.tb04356.x"},{"key":"2020021218481207200_REF13","doi-asserted-by":"crossref","unstructured":"Duquesnoy RJ, Anderson AJ, Tomasulo PA, Aster RH. ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood. 1979;54: 595-599.","DOI":"10.1182\/blood.V54.3.595.595"},{"key":"2020021218481207200_REF14","doi-asserted-by":"crossref","unstructured":"Heal JM, Mullin A, Blumberg N. The importance of ABH antigens in platelet crossmatching. Transfusion. 1989;29: 514-520.","DOI":"10.1046\/j.1537-2995.1989.29689318450.x"},{"key":"2020021218481207200_REF15","unstructured":"American Association of Blood Banks. Technical Manual. 14th ed. Bethesda, MD: AABB; 2002."},{"key":"2020021218481207200_REF16","doi-asserted-by":"crossref","unstructured":"Brand A, Sintnicolaas K, Claas FHJ, Eernisse JG. ABH antibodies causing platelet transfusion refractoriness. Transfusion. 1986;26: 463-466.","DOI":"10.1046\/j.1537-2995.1986.26587020127.x"},{"key":"2020021218481207200_REF17","doi-asserted-by":"crossref","unstructured":"Lee EJ, Schiffer CA. ABO compatibility can influence the results of platelet transfusion. Transfusion. 1989;29: 384-389.","DOI":"10.1046\/j.1537-2995.1989.29589284135.x"},{"key":"2020021218481207200_REF18","doi-asserted-by":"crossref","unstructured":"Skogen B, Rossebo Hansen B, Husebekk A, Havnes T, Hannestad K. Minimal expression of blood group A antigen on thrombocytes from A2 individuals. Transfusion. 1988;28: 456-459.","DOI":"10.1046\/j.1537-2995.1988.28588337336.x"},{"key":"2020021218481207200_REF19","doi-asserted-by":"crossref","unstructured":"Julmy F, Achermann F, Schulzki T, Carrel T, Ny-degger U. PLTs of blood group A1 donors express increased surface A antigen owing to apheresis and prolonged storage. Transfusion. 2003;43: 1378-1385.","DOI":"10.1046\/j.1537-2995.2003.00526.x"},{"key":"2020021218481207200_","doi-asserted-by":"crossref","unstructured":"Norol F, Kuentz M, Cordonnier C, et al. Influence of clinical status on the efficiency of stored platelet transfusion. Br J Haematol. 1994;86; 125-129.","DOI":"10.1111\/j.1365-2141.1994.tb03262.x"},{"key":"2020021218481207200_REF21","doi-asserted-by":"crossref","unstructured":"Slichter SJ. Algorithm for managing the platelet refractory patient. J Clin Apheresis. 1997;12: 4-9.","DOI":"10.1002\/(SICI)1098-1101(1997)12:1<4::AID-JCA2>3.0.CO;2-E"},{"key":"2020021218481207200_REF22","doi-asserted-by":"crossref","unstructured":"Kelton JG, Hamid C, Aker S, Blajchman M. The amount of blood group A substance on platelets is proportional to the amount in the plasma. Blood. 1982;59: 980-985.","DOI":"10.1182\/blood.V59.5.980.980"},{"key":"2020021218481207200_REF23","doi-asserted-by":"crossref","unstructured":"Curtis BR, Edwards JT, Hessner MJ, Klein JP, Aster RH. Blood group A and B antigens are strongly expressed on platelets of some individuals. Blood. 2000;96: 1574-1581.","DOI":"10.1182\/blood.V96.4.1574"},{"key":"2020021218481207200_REF24","doi-asserted-by":"crossref","unstructured":"Ogasawara K, Ueki J, Takenaka M, Furihata K. Study on the expression of ABH antigens on platelets. Blood. 1993;82: 993-999.","DOI":"10.1182\/blood.V82.3.993.993"},{"key":"2020021218481207200_REF25","doi-asserted-by":"crossref","unstructured":"Cooling LLW, Walker KE, Gille T, Koerner TAW. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect Immun. 1998;66: 4355-4366.","DOI":"10.1128\/IAI.66.9.4355-4366.1998"},{"key":"2020021218481207200_REF26","doi-asserted-by":"crossref","unstructured":"Koerner TAW, Weinfeld HM, Bullard LSB, Williams LCJ. Antibodies against platelet glycosphingolipids: detection in serum by quantitative HPTLC-autoradiography and association with autoimmune and alloimmune processes. Blood. 1989;74: 274-284.","DOI":"10.1182\/blood.V74.1.274.274"},{"key":"2020021218481207200_REF27","unstructured":"Rinder H, Munz UJ, Ault KA, Bonan JL, Smith BR. Reticulated platelets in the evaluation of thrombopoietic disorders. Arch Pathol Lab Med. 1993;117: 606-610."},{"key":"2020021218481207200_REF28","doi-asserted-by":"crossref","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature. 1970;227: 680-689.","DOI":"10.1038\/227680a0"},{"key":"2020021218481207200_REF29","unstructured":"Bruning FL, Kintz BL. Computational Handbook of Statistics. Glenview, IL: HarperCollins Publisher; 1987."},{"key":"2020021218481207200_REF30","doi-asserted-by":"crossref","unstructured":"Dunstan RA, Simpson MB, Knowles RW, Rosse WF. The origin of ABH antigens on human platelets. Blood. 1985;65: 615-619.","DOI":"10.1182\/blood.V65.3.615.615"},{"key":"2020021218481207200_REF31","doi-asserted-by":"crossref","unstructured":"Dunstan RA, Simpson MB. Heterogenous distribution of antigens on human platelets demonstrated by fluorescence flow cytometry. Br J Haematol. 1985:61: 603-609.","DOI":"10.1111\/j.1365-2141.1985.tb02873.x"},{"key":"2020021218481207200_REF32","doi-asserted-by":"crossref","unstructured":"Fibach E, Sharon R. Changes in ABH antigen expression on red cells during in vivo aging: a flow cytometric analysis. Transfusion. 1994;34: 328-332.","DOI":"10.1046\/j.1537-2995.1994.34494233581.x"},{"key":"2020021218481207200_REF33","doi-asserted-by":"crossref","unstructured":"Skovlund VR. ABH and related histo-blood group antigens in normal and malignant human endometrium in relation to genetic and hormonal factors. APMIS Supplementum. 1997;69: 1-33.","DOI":"10.1111\/j.1600-0463.1997.tb05597.x"},{"key":"2020021218481207200_REF34","doi-asserted-by":"crossref","unstructured":"Bord S, Vedi S, Beavan SR, Horner A, Compston JE. Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling. Bone. 2000;27: 397-401.","DOI":"10.1016\/S8756-3282(00)00336-7"},{"key":"2020021218481207200_","doi-asserted-by":"crossref","unstructured":"Khetawat G, Faraday N, Nealen ML, et al. Human megakaryocytes and platelets contain the estrogen receptor \u03b2 and androgen receptor (AR): testosterone regulates AR expression. Blood. 2000;95: 2289-2296.","DOI":"10.1182\/blood.V95.7.2289"},{"key":"2020021218481207200_","doi-asserted-by":"crossref","unstructured":"Faraday N, Goldschmidt-Clermont PJ, Bray PF. Gender differences in platelet GPIIb-IIIa activation. Thromb Haemost. 1997;77: 748-754.","DOI":"10.1055\/s-0038-1656045"},{"key":"2020021218481207200_REF37","doi-asserted-by":"crossref","unstructured":"Jones SB, Bylund DB, Rieser CA, Shekim WO, Byer JA, Carr GN. \u03b12-adrenergic receptor binding in human platelets: alterations during the men-strual cycles. Clin Pharmacol Ther. 1983;34: 90-96.","DOI":"10.1038\/clpt.1983.135"},{"key":"2020021218481207200_REF38","doi-asserted-by":"crossref","unstructured":"Hoskins LC, Larson G, Naff GB. Blood group A immunodeterminants on human red cells differ in biologic activity and sensitivity to \u03b1-N-acetyl-galactosaminidase. Transfusion. 1995;35: 813-821.","DOI":"10.1046\/j.1537-2995.1995.351096026361.x"},{"key":"2020021218481207200_REF39","doi-asserted-by":"crossref","unstructured":"Lindstrom K, Breimer ME, Jovall P-A, Lanne B, Pimlott W, Samuelsson BE. Non-acid glycosphin-golipid expression in plasma of an A1 Le(a-b+) secretor human individual: identification of an ALeb heptaglycosylceramide as major blood group component. J Biochem. 1992;111: 337-345.","DOI":"10.1093\/oxfordjournals.jbchem.a123759"},{"key":"2020021218481207200_REF40","doi-asserted-by":"crossref","unstructured":"Daniels G. Human Blood Groups. Oxford, United Kingdom: Blackwell Science; 2002.","DOI":"10.1002\/9780470987018"},{"key":"2020021218481207200_REF41","doi-asserted-by":"crossref","unstructured":"Bird GWG. A-intermediates in Maharastrian blood donors. Vox Sang. 1964;9: 629-630.","DOI":"10.1159\/000464871"},{"key":"2020021218481207200_","doi-asserted-by":"crossref","unstructured":"Brain P. Subgroups of A in the South African Bantu. Vox Sang. 1966;11: 686-698.","DOI":"10.1159\/000465174"},{"key":"2020021218481207200_REF43","unstructured":"Salthe M, Bhatia HM. Serology and genetics of the A1 high H subgroup. Vox Sang. 1974;26: 374-382."},{"key":"2020021218481207200_REF44","doi-asserted-by":"crossref","unstructured":"Blumberg N, Heal JM, Kirkley SA, DiPersio JF, Rapoport AP, Rowe JM. Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: a cost analysis. Am J Hematol. 1995;48: 108-115.","DOI":"10.1002\/ajh.2830480208"},{"key":"2020021218481207200_REF45","doi-asserted-by":"crossref","unstructured":"Fishbein TM, Emre S, Guy SR, et al. Safe transplantation of blood type A2 livers to blood type O recipients. Transplantation. 1999;67: 1071-1073.","DOI":"10.1097\/00007890-199904150-00024"},{"key":"2020021218481207200_REF46","doi-asserted-by":"crossref","unstructured":"Nelson PW, Helling TS, Shield CF, Beck M, Bryan CF. Current experience with renal transplantion across the ABO barrier. Am J Surgery. 1992;164: 541-545.","DOI":"10.1016\/S0002-9610(05)81197-3"},{"key":"2020021218481207200_REF47","doi-asserted-by":"crossref","unstructured":"Olsson ML, Irshaid NM, Hosseini-Maaf B, et al. Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles. Blood. 2001;98: 1585-1593.","DOI":"10.1182\/blood.V98.5.1585"},{"key":"2020021218481207200_REF48","doi-asserted-by":"crossref","unstructured":"Dunstan RA. The expression of ABH antigens during in vitro megakaryocyte maturation: origin of heterogeneity of antigen density. Br J Haematol. 1986;62: 587-593.","DOI":"10.1111\/j.1365-2141.1986.tb02971.x"},{"key":"2020021218481207200_REF49","doi-asserted-by":"crossref","unstructured":"Koda Y, Soejima M, Kimura H. Changing transcription start sites in H-type \u03b1(1,2)fucosyltransferase gene (FUT1) during differentiation of the human erythroid lineage. Eur J Biochem. 1998;256: 379-387.","DOI":"10.1046\/j.1432-1327.1998.2560379.x"},{"key":"2020021218481207200_REF50","doi-asserted-by":"crossref","unstructured":"Kominato Y, Hata Y, Takizawa H, Tsuchiya T, Tsukada J, Yamamoto F. Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promotor region. J Biol Chem. 1999;274: 37240-37250.","DOI":"10.1074\/jbc.274.52.37240"},{"key":"2020021218481207200_REF51","doi-asserted-by":"crossref","unstructured":"Kominato Y, Hata Y, Takizawa H, et al. Alternative promotor identified between a hypermethylated upstream region of repetitive elements and a CpG island in human ABO histo-blood group genes. J Biol Chem. 2002;277: 37936-37948.","DOI":"10.1074\/jbc.M204238200"},{"key":"2020021218481207200_REF52","doi-asserted-by":"crossref","unstructured":"Wilcynska Z, Miller-Podraza H, Koscielak J. The contribution of different glycoconjugates to the total ABH blood group activity of human erythrocytes. FEBS Lett. 1980;112: 277-279.","DOI":"10.1016\/0014-5793(80)80197-9"},{"key":"2020021218481207200_REF53","doi-asserted-by":"crossref","unstructured":"Kobata A, Grollman EF, Ginsburg V. An enzymatic basis for blood type A in humans. Arch Biochem Biophys. 1968;124: 609-612.","DOI":"10.1016\/0003-9861(68)90373-1"},{"key":"2020021218481207200_REF54","unstructured":"Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN. Hemostasis and Thrombosis: Basic Principles and Practice, 4th ed. Philadelphia, PA: Lippincott; 2001."},{"key":"2020021218481207200_REF55","doi-asserted-by":"crossref","unstructured":"Tsuji T, Osawa T. Structures of the carbohydrate chains of membrane glycoproteins IIb and IIIa of human platelets. J Biochem. 1986;100: 1387-1398.","DOI":"10.1093\/oxfordjournals.jbchem.a121845"},{"key":"2020021218481207200_REF56","doi-asserted-by":"crossref","unstructured":"Lopez JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ. Cloning of the \u03b1 chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich \u03b12-glycoprotein. Proc Natl Acad Sci U S A. 1987;84: 5615-5619.","DOI":"10.1073\/pnas.84.16.5615"},{"key":"2020021218481207200_REF57","doi-asserted-by":"crossref","unstructured":"Tsuji T, Tsunchesa S, Watanabe Y, Yamamoto K, Tohyama H, Osawa T. The carbohydrate moiety of human platelet glycocalicin: the structure of the major Ser\/Thr-linked sugar chain. J Biol Chem. 1983;258: 6335-6339.","DOI":"10.1016\/S0021-9258(18)32413-X"},{"key":"2020021218481207200_REF58","doi-asserted-by":"crossref","unstructured":"Korrel SAM, Clemetson KJ, van Halbeek H, Kamerling JP, Sixma JJ, Vliegenthart FG. Structural studies on the O-linked carbohydrate chains of human platelet glycocalicin. Eur J Biochem. 1984;140: 571-576.","DOI":"10.1111\/j.1432-1033.1984.tb08140.x"},{"key":"2020021218481207200_REF59","doi-asserted-by":"crossref","unstructured":"Tsuji T, Osawa T. Purification and chemical characterization of human platelet membrane glycoprotein IV. J Biochem. 1986;100: 1077-1085.","DOI":"10.1093\/oxfordjournals.jbchem.a121787"},{"key":"2020021218481207200_REF60","doi-asserted-by":"crossref","unstructured":"Tsuji T, Osawa T. The carbohydrate moiety of human platelet glycocalicin: the structures of the major Asn-linked sugar chains. J Biochem. 1987;101: 241-249.","DOI":"10.1093\/oxfordjournals.jbchem.a121897"},{"key":"2020021218481207200_REF61","doi-asserted-by":"crossref","unstructured":"Korrel SAM, Clemetson KJ, van Halbeek H, Kamerling JP, Sixma JJ, Vliegenthart FG. Identification of a tetrasialylated monofucosylated tetraan-tennary N-linked carbohydrate chain in human platelet glyocalicin. FEBS Lett. 1988;228: 321-326.","DOI":"10.1016\/0014-5793(88)80024-3"},{"key":"2020021218481207200_REF62","doi-asserted-by":"crossref","unstructured":"Gerken TA, Owens CL, Pasumarthy M. Site-specific core 1 O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide: evidence for the modulation of glycan length by peptide sequence. J Biol Chem. 1998;273: 26580-26588.","DOI":"10.1074\/jbc.273.41.26580"},{"key":"2020021218481207200_REF63","doi-asserted-by":"crossref","unstructured":"Gerken TA, Gilmore M, Zhang J. Determination of the site-specific oligosaccharide distribution of the O-glycans attached to the porcine submaxillary mucin tandem repeat: further evidence for the modulation of O-glycan side chain structures by peptide sequence. J Biol Chem. 2002;277: 7736-7751.","DOI":"10.1074\/jbc.M111690200"},{"key":"2020021218481207200_REF64","doi-asserted-by":"crossref","unstructured":"Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion. 1999;39: 179-187.","DOI":"10.1046\/j.1537-2995.1999.39299154733.x"},{"key":"2020021218481207200_","doi-asserted-by":"crossref","unstructured":"Worel N, Kalhs P, Keil F, et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion. 2003;43: 1153-1161.","DOI":"10.1046\/j.1537-2995.2003.00465.x"},{"key":"2020021218481207200_REF66","doi-asserted-by":"crossref","unstructured":"Paltiel O, Cournoyer D, Rybka W. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin. Transfusion. 1993;33: 418-421.","DOI":"10.1046\/j.1537-2995.1993.33593255604.x"},{"key":"2020021218481207200_REF67","doi-asserted-by":"crossref","unstructured":"Benjamin RJ, Antin JH. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity [letter]. Transfusion. 1999;39: 1273-1274.","DOI":"10.1046\/j.1537-2995.1999.39111273.x"},{"key":"2020021218481207200_","doi-asserted-by":"crossref","unstructured":"Gordon B, Tarantolo S, Ruby E, et al. Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 1998;22: 999-1003.","DOI":"10.1038\/sj.bmt.1701464"},{"key":"2020021218481207200_REF69","doi-asserted-by":"crossref","unstructured":"Badros A, Tricot G, Toor A, et al. ABO mismatch may effect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion. 2002;42: 205-209.","DOI":"10.1046\/j.1537-2995.2002.00027.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/8\/3356\/1709671\/zh800805003356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/8\/3356\/1709671\/zh800805003356.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T01:34:35Z","timestamp":1625189675000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/8\/3356\/20609\/Determinants-of-ABH-expression-on-human-blood"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,15]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-08-3080","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,15]]}}}